Gartner Magic Quadrant Contact Center as a Service (CCaaS) 2017

Gartner Again Names Serenova Challenger in New 2017 CCaaS Magic Quadrant Report

Serenova has once again been named a Challenger in the all-new 2017 Gartner Magic Quadrant for Contact Center (CCaaS) Report!

This year Gartner profiles 11 solution providers to help you make the right choice as you look to undertake a new CCaaS project. Learn what’s driving the market demand for CCaaS, who the key players are and why Gartner placed Serenova as a Challenger.

Get ebook Now

Key Takeaways:

  • Magic Quadrant: Contact Center as a Service, North America 
  • Vendor Strengths and Cautions
  • Market Overview

Sneak Peek:

Consider Serenova for CCaaS solutions across a wide variety of deployment sizes, including those with more than 1,000 agents.


Serenova's offerings are designed for ease of deployment, even for large and very large deployments. Many deployments are completed using only phone support, with no professional services required.

By routing calls directly through a telco, and not rerouting them through its own data centers, Serenova provides good call quality while removing some of the telco costs associated with call-rerouting topologies.

Serenova bundles CSP services with its core offering. This enables services to be activated quickly and supports environments that experience significant bursts in call volume.

Download it now

ContactBabel US Contact Center Decision-Makers' Guide 2017

Nuffield Health - Serenova-Unify Customer Success Story


Gartner, Magic Quadrant for Contact Center as a Service, Drew Kraus, Steve Blood, Daniel O'Connell, October 24, 2016

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.